2011
DOI: 10.1111/j.1532-5415.2011.03365.x
|View full text |Cite
|
Sign up to set email alerts
|

The World of Dementia Beyond 2020

Abstract: Counterpoised against dire projections of the tripling of the prevalence of dementia over the next 40 years are major developments in diagnostic biomarkers, neuroimaging, the molecular biology of Alzheimer's disease (AD), epidemiology of risk and protective factors, and drug treatments-mainly targeting the amyloid pathway, tau protein, and immunotherapy-that may have the potential to modify the progression of AD. Drug combinations and presymptomatic treatments are also being investigated. Previous trials of de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
54
0
3

Year Published

2012
2012
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(57 citation statements)
references
References 20 publications
0
54
0
3
Order By: Relevance
“…Given the higher prevalence of dementia in secondary and tertiary care settings, high number of undiagnosed patients, and new developing available treatment, early recognizing of dementia is crucial. [2][3][4][5][6] The most commonly used and studied test, which has acceptable accuracy is the Mini-Mental State Examination (MMSE). 2,4,[7][8][9] Its sensitivity varies from 71% to 92% and specificity ranges from 56% to 96% depending on the cutoff point used for an abnormal test.…”
Section: Introductionmentioning
confidence: 99%
“…Given the higher prevalence of dementia in secondary and tertiary care settings, high number of undiagnosed patients, and new developing available treatment, early recognizing of dementia is crucial. [2][3][4][5][6] The most commonly used and studied test, which has acceptable accuracy is the Mini-Mental State Examination (MMSE). 2,4,[7][8][9] Its sensitivity varies from 71% to 92% and specificity ranges from 56% to 96% depending on the cutoff point used for an abnormal test.…”
Section: Introductionmentioning
confidence: 99%
“…AD is a neurodegenerative condition that results in deterioration of memory and other cognitive functions and ultimately leads to death [1]. Approximately 35 million people worldwide are affected with dementia and this number is expected to reach 65 million in 2030 and 113 million by 2050 [2]. Dementia rates are expected to increase in the least developed and developing countries, as estimates suggest that 71% of the expected 81.1 million dementia cases will be in the developing world by 2040 [3].…”
Section: Introductionmentioning
confidence: 99%
“…Thus, relatives have expressed the opinion that research for the improvement of quality of life of their relative with dementia should be supported but not research for prolonging life [36].…”
Section: Assessment Of Capacity To Consentmentioning
confidence: 99%